Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-04-06 @ 7:36 AM
Study NCT ID:
NCT06756269
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2024-12-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
Sponsor:
Shanghai Bovax Biotechnology Co., Ltd.
Organization: